FDA Inspection
CBI Laboratories, Inc. dba Voyant Beauty LLC.CBI Laboratories, Inc. dba Voyant Beauty LLC. – FDA Inspection, Dec 5, 2017
Record Details
This FDA Inspection record concerns CBI Laboratories, Inc. dba Voyant Beauty LLC., with an inspection on December 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 5, 2017
- Product Type
- Drugs
View Company Profile
ID · 6dd46901-442b-4285-9c57-729fe21c8f09
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1033859
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CBI Laboratories, Inc. dba Voyant Beauty LLC.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CBI Laboratories, Inc. dba Voyant Beauty LLC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.